查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466444

豬源疫苗市場：按適應症、技術、最終用戶分類 - 2024-2030 年全球預測

Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年豬源疫苗市場規模為17.1億美元，預計2024年將達18.2億美元，2030年將達27億美元，複合年成長率為6.72%。

豬源疫苗是預防豬多種疾病的免疫製劑。這些疫苗的目的是刺激豬的免疫系統並增強對引起疾病的病毒和細菌等病原體的防禦能力。透過模仿感染，豬的身體準備好識別並對抗未來遇到的真正病原體。豬隻病發生率的增加和全球豬肉產品消費量的增加是對豬源疫苗需求的主要驅動力。此外，補貼和宣傳計劃等政府支持措施正在促進疫苗的使用。然而，對低溫運輸基礎設施的需求帶來了物流挑戰，特別是在開發中國家。此外，豬品種之間免疫反應的差異可能會影響疫苗的功效，並為豬源疫苗的開發和引進帶來障礙。然而，主要參與者正在探索奈米技術、基因編輯策略和精準醫學等新技術，以確保開發出能夠克服豬源疫苗性能挑戰的客製化疫苗。此外，對在不影響安全性的情況下增強免疫反應的新佐劑的研究以及無針注射方法的開發可以提高疫苗的吸收並減少對動物的壓力。

主要市場統計
基準年[2023] 17.1億美元
預測年份 [2024] 18.2億美元
預測年份 [2030] 27億美元
複合年成長率（%） 6.72%

技術 基因工程和分子生物學技術的進步將推動重組疫苗的創新。

結合疫苗是多醣抗原與載體分子融合或連接的疫苗。豬源疫苗一般用於針對病原體含有多醣的疾病，其免疫抗原性較低。當針對由帶有多醣膠囊的細菌引起的疾病時，此類疫苗特別有用。 DNA 疫苗利用遺傳物質來誘發免疫反應。一旦遺傳物質進入動物細胞，它就會被用來產生抗原，刺激免疫系統。這些疫苗對於獸醫領域來說仍然相對較新。此類疫苗可能是優選的，因為它們可以快速開發並且可以提供長期免疫力而不需要佐劑。去活化疫苗含有殺死的病原體。它不會引起感染疾病，但會引起免疫反應。這些疫苗被認為是安全且穩定的。減毒活病毒疫苗是活的減毒病原體。它非常模仿自然感染，通常提供強大、持久的免疫力。重組疫苗使用透過基因工程技術創建的病原體的部分（通常是蛋白質）。該成分用於刺激免疫反應，而不存在引入活病原體的風險。類毒素疫苗是透過去活化某些細菌產生的毒素而製成的。這些疫苗用於預防由細菌產生的毒素引起的疾病，而不是細菌本身。在處理主要由細菌毒素引起的疾病時，類毒素疫苗是首選。

最終用戶：養豬場大規模疫苗接種計畫的需求不斷增加

生豬/生豬養殖場部門包括主要從事肉類生產生豬飼養的營業單位。這些農場對疫苗的需求是為了維持無疾病的環境、提高牲畜生長表現並最終提高農民的盈利。生豬和養豬場通常需要涵蓋多種常見豬病的疫苗，包括豬繁殖與呼吸綜合症 (PRRS)、豬流感和口蹄疫。獸醫醫院和診所治療各種動物，包括豬。作為常規健康檢查或特定疾病爆發的一部分，這些設施通常會遇到豬和其他豬進行疫苗接種。在這種環境下，首選具有廣泛功效和快速產生免疫力的疫苗。由於這些設施針對的是個人或小群體，因此他們通常更喜歡單劑量、更易於管理或包裝尺寸較小的疫苗。

區域洞察

美洲，特別是美國和加拿大，由於其大型養豬場和對動物健康管理的重視，擁有完善的豬疫苗市場。該國消費者對豬隻繁殖與呼吸綜合症（PRRS）和豬流感等地方性疾病疫苗接種的需求很高。生產者經常採用最新的疫苗，他們的購買行為表明他們願意為豬群投資先進的解決方案。美國的研究最近集中在開發更有效、提供更長時間免疫力的疫苗。對生物技術公司和美國農業部動植物衛生檢驗局 (APHIS) 獸醫生物製品計劃等政府生技藥品的投資將繼續加強該行業，這反映了我們的努力。歐洲、中東和非洲國家是多元化的市場，有嚴格的動物福利和衛生法規。歐洲消費者要求符合高安全標準的疫苗，從而增加了對有品質保證的疫苗的需求。歐盟的地平線 2020 計畫正在大力投資豬病研究，這有助於開發新的高效疫苗。在亞太地區，中國豬肉市場高度發達，增加了對豬肉市場的需求。在亞太地區生豬養殖業蓬勃發展的印度，對豬源疫苗的需求正在增加，儘管成長幅度不大。消費者的需求圍繞著負擔得起且可用的疫苗，以及對成本敏感的購買行為。政府正在透過支持疫苗接種和動物健康計劃的措施來鼓勵養豬業的發展。

FPNV定位矩陣

FPNV定位矩陣對於評估豬源疫苗市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對豬隻疫苗市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭力評估及資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.豬源疫苗市場規模及預測如何？

2.在豬疫苗市場預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.豬源疫苗市場的技術趨勢與法規結構是什麼？

4.豬源疫苗市場主要廠商的市場佔有率如何？

5. 進入豬源疫苗市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地豬病流行率不斷上升
      • 對優質豬肉的需求增加
      • 政府支持動物健康的舉措
    • 抑制因素
      • 豬疫苗研發高成本、儲存複雜
    • 機會
      • 豬疫苗的技術進步
      • 投資情勢有利於新型豬源疫苗生產
    • 任務
      • 豬源疫苗的可得性和認知度有限，且有副作用
  • 市場區隔分析
    • 技術：基因工程和分子生物學技術的進步推動重組疫苗的創新
    • 最終用戶：生豬養殖場大規模疫苗接種計畫的需求不斷增加
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章 豬源疫苗市場適應症

  • 關節炎
  • 腹瀉
  • 豬環狀病毒相關疾病
  • 豬繁殖與呼吸綜合症
  • 豬流感

第7章豬源疫苗市場：依技術分類

  • 結合疫苗
  • DNA疫苗
  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 類毒素疫苗

第8章豬源疫苗市場：依最終用戶分類

  • 養豬場
  • 獸醫診所/醫院

第9章 南北美洲豬源疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太豬源疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲豬源疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Zoetis 在英國推出 Circomax
    • 默克動物保健推出三合一豬疫苗
    • Elanco 是 Aptimmune 的 PRRS 去活化自體疫苗的美國獨家經銷商

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-742BD5183CF6

[185 Pages Report] The Porcine Vaccines Market size was estimated at USD 1.71 billion in 2023 and expected to reach USD 1.82 billion in 2024, at a CAGR 6.72% to reach USD 2.70 billion by 2030.

Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. These vaccines are created to stimulate the porcine immune system, enabling it to develop defenses against pathogens such as viruses or bacteria that can cause illness. By mimicking the infection, they prepare the swine's body to recognize and combat the actual pathogens should they be encountered in the future. The rise in the incidence of swine diseases and the growing global consumption of pork products are major driving factors behind the need for porcine vaccines. Furthermore, supportive government initiatives, including subsidies and awareness programs, have encouraged the use of vaccines. However, the need for a cold chain infrastructure creates logistical challenges, particularly in developing countries. Furthermore, the variability in the immune response of different pig breeds can impact vaccine effectiveness and create hurdles for the development and adoption of porcine vaccines. However, key players are exploring novel technologies such as nanotechnology, gene editing strategies, and precision medicine to ensure the development of customized vaccines that can overcome the performance challenges of porcine vaccines. Moreover, investigating new adjuvants to enhance immune response without compromising safety and developing needle-free administration could improve vaccine uptake and reduce stress on animals.

KEY MARKET STATISTICS
Base Year [2023] USD 1.71 billion
Estimated Year [2024] USD 1.82 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 6.72%

Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies

A conjugate vaccine refers to a vaccine that is composed of a polysaccharide antigen fused or conjugated to a carrier molecule. In porcine vaccines, they are used to target diseases where the pathogens have polysaccharide coatings, which are generally poorly immunogenic. Such vaccines are especially useful for targeting diseases caused by bacteria with polysaccharide capsules. DNA vaccines utilize genetic material to induce an immune response. When the genetic material enters the animal's cells, it is used to produce the antigen which in turn stimulates the immune system. These vaccines are still relatively novel in the veterinary field. Such vaccines may be preferred for their potential for rapid development and their ability to provide long-lasting immunity without the need for adjuvants. Inactivated vaccines contain pathogens that have been killed. They cannot cause an infection but still prompt an immune response. These vaccines are considered safe and stable. Live attenuated vaccines contain a live and weakened version of the pathogen. They closely mimic a natural infection and typically provide strong, long-lasting immunity. Recombinant vaccines use a piece of the pathogen (typically a protein) created using the techniques of genetic engineering. This component is used to stimulate an immune response without the risk of introducing a live pathogen. Toxoid vaccines are created by inactivating the toxins produced by certain bacteria. These vaccines are used to protect against diseases that are caused not by the bacteria itself, but by the toxins they produce. Toxoid vaccines are the preferred option when addressing illnesses where the primary concern is the bacterial toxin.

End User: Growing need for mass vaccination programs in the hog/pig production farm

The hog/pig production farm sector includes entities involved in raising pigs primarily for meat production. The need for vaccines in such farms is driven by the requirement to maintain a disease-free environment, enhance growth performance of the animals, and ultimately increase farmer profitability. Hog and pig production farms typically require vaccines thar can address a wide spectrum of common swine diseases, such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and foot and mouth disease, among others. Veterinary clinics and hospitals cater to a broad range of animals, including pigs. These facilities generally encounter pigs and other swine for vaccinations as part of routine health checks or specific disease outbreaks. The vaccine preferences in this environment are for products with broad-spectrum efficacy and rapid onset of immunity. Since these facilities might be dealing with individual animals or small herds, they often prefer single-dose, easy-to-administer vaccines that are also available in smaller package sizes.

Regional Insights

In the Americas region, particularly the U.S. and Canada, the porcine vaccine market is well-established due to the extensive pig farming industry and a strong emphasis on animal health management. The country sees a significant consumer need for vaccinations against prevalent diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and others. Producers often adopt the latest vaccines, and purchasing behavior indicates a readiness to invest in advanced solutions for swine herds. Recent research in the U.S. has focused on developing vaccines with improved efficacy and longer immunity periods. Investments in biotechnology companies and government initiatives such as the Veterinary Biologics Program under the United States Department of Agriculture(USDA)-Animal & Plant Health Inspection Service(APHIS) reflect ongoing efforts to strengthen the sector. The EMEA countries represent a diverse market with stringent animal welfare and health regulations. The European consumer requires vaccines that comply with high safety standards, leading to a demand for quality-assured vaccines. The EU's Horizon 2020 program has seen substantial investments in research addressing swine diseases, which propels the development of new and efficient vaccines. In the APAC region, China represents a highly evolved market for pig meat, thereby accentuating the need for porcine markets. India, with an emerging pig farming industry in the APAC region, presents a moderate but growing demand for porcine vaccines. Consumer needs revolve around affordable and accessible vaccines due to cost-sensitive purchasing behaviors. The government has been encouraging the growth of the swine industry through initiatives that provide support for vaccinations and animal health programs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Porcine Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Porcine Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Arko Laboratories, AVAC Vietnam Joint Stock Company, Bayer AG, Bimeda Holdings PLC, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Endovac Animal Health, FATRO S.p.A., Formosa Biomedical Inc., Genvax Technologies, Inc., HIPRA, S.A., Indian Immunologicals Ltd., KM Biologics Co., Ltd., Kyoto Biken Laboratories, Inc., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Medgene Labs, Merck & Co., Inc., Nisseiken Co., Ltd., PBS Animal Health, Phibro Animal Health Corporation, Virbac SA, Yenher Agro-Products Sdn. Bhd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Porcine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Arthritis
    • Diarrhea
    • Porcine Circovirus Associated Disease
    • Porcine Reproductive & Respiratory Syndrome
    • Swine Influenza
  • Technology
    • Conjugate Vaccines
    • DNA Vaccines
    • Inactivated Vaccines
    • Live attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • End User
    • Hog/Pig Production Farm
    • Veterinary Clinics/Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Porcine Vaccines Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Porcine Vaccines Market?

3. What are the technology trends and regulatory frameworks in the Porcine Vaccines Market?

4. What is the market share of the leading vendors in the Porcine Vaccines Market?

5. Which modes and strategic moves are suitable for entering the Porcine Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in Prevalence of Swine Diseases Worldwide
      • 5.1.1.2. Increasing Demand for High-Quality Pork Meat
      • 5.1.1.3. Government Initiatives to Support Animal Health
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Porcine Vaccine Development and Complex Storage Issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Porcine Vaccine
      • 5.1.3.2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
    • 5.2.2. End User: Growing need for mass vaccination programs in the hog/pig production farm
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Porcine Vaccines Market, by Indication

  • 6.1. Introduction
  • 6.2. Arthritis
  • 6.3. Diarrhea
  • 6.4. Porcine Circovirus Associated Disease
  • 6.5. Porcine Reproductive & Respiratory Syndrome
  • 6.6. Swine Influenza

7. Porcine Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. Conjugate Vaccines
  • 7.3. DNA Vaccines
  • 7.4. Inactivated Vaccines
  • 7.5. Live attenuated Vaccines
  • 7.6. Recombinant Vaccines
  • 7.7. Toxoid Vaccines

8. Porcine Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Hog/Pig Production Farm
  • 8.3. Veterinary Clinics/Hospitals

9. Americas Porcine Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Porcine Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Porcine Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zoetis Launches Circomax In The UK
    • 12.3.2. Merck Animal Health Launches 3-In-One Swine Vaccine
    • 12.3.3. Elanco is Exclusive U.S. Distributor of Aptimmune's PRRS Killed Autogenous Vaccine

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PORCINE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. PORCINE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PORCINE VACCINES MARKET DYNAMICS
  • FIGURE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PORCINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PORCINE VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 294. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023